# Akso Health Group: Form 20-F for the period ended Mar 31, 2024

- Company: [Akso Health Group](/companies/ahg.md) (CIK 1702318)
- Form: 20-F
- Filed: 2024-07-30
- Accepted by EDGAR: Jul 30, 2024, 16:05 ET
- Period: 2024-03-31
- Accession: 0001013762-24-002658
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1702318/000101376224002658/ea0208034-20f_aksohealth.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1702318/000101376224002658/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-04-01 to 2024-03-31 | $2.4m | us-gaap:Revenues |
| Gross profit | 12 months, 2023-04-01 to 2024-03-31 | $122.1k | us-gaap:GrossProfit |
| Operating income | 12 months, 2023-04-01 to 2024-03-31 | −$8.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2023-04-01 to 2024-03-31 | $25.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-04-01 to 2024-03-31 | −$9.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-04-01 to 2024-03-31 | −$0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-04-01 to 2024-03-31 | −$0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-04-01 to 2024-03-31 | 141,516,777 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-04-01 to 2024-03-31 | $1.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2024-03-31 | $85.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-03-31 | $142.0m | us-gaap:AssetsCurrent |
| Total assets | at 2024-03-31 | $142.0m | us-gaap:Assets |
| Current liabilities | at 2024-03-31 | $3.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-03-31 | $3.6m | us-gaap:Liabilities |
| Shareholders' equity | at 2024-03-31 | $138.4m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2024-03-31 | 437,170,960 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1702318/000101376224002658/ea0208034-20f_aksohealth.htm

Filed Jul 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001013762-24-002658. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.